Activity and Diffusion of Tigecycline (GAR-936) in Experimental Enterococcal Endocarditis

The activity of tigecycline (GAR-936), a novel glycylcycline, was investigated in vitro and in experimental endocarditis due to the susceptible Enterococcus faecalis JH2-2 strain, its VanA type transconjugant BM4316, and a clinical VanA type strain, E. faecium HB217 resistant to tetracycline. MICs o...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Lefort, Agnès, Lafaurie, Matthieu, Massias, Laurent, Petegnief, Yolande, Saleh-Mghir, Azzam, Muller-Serieys, Claudette, Le Guludec, Dominique, Fantin, Bruno
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC148965/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12499194/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.1.216-222.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!